drugset / Trial / NCT01271582

Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients

NCT01271582

Phase 4 Unknown 1500 enrolled Asan Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the association between UGT1A1 polymorphisms and neutropenia and diarrhea in Korean patients with advanced colorectal or gastric cancer treated with FOLFIRI regimen.

Timeline

Start
2009-01
Primary completion
2014-06
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule 150 mg/m2
Subject Irinotecan Small molecule 180 mg/m2
Background Leucovorin Small molecule 20 mg/m2
Background Leucovorin Small molecule 200 mg/m2
Background fluorouracil Small molecule 400 mg/m2
Background fluorouracil Small molecule 2400 mg/m2